Celltrion signs $127.5M biosimilar supply contracts in multiple countries

Celltrion has signed contracts worth about 160.1 billion won ($127.5 million) to supply biosimilar products including Remsima, CT-P16, and Herzuma in multiple countries.

“Celltrion has signed fresh contracts worth about 160.1 billion won ($127.5 million) in multiple countries to deliver its key biosimilar products.”pulse.mk.co.kr

• 1 source
• pulse.mk.co.krCelltrion nabs $127.5 mn biosim contracts - 매일경제 영문뉴스 펄스(Pulse)May 25, 2022

Summarized from public sources; check the original articles before acting on it.